Updates on Clinical and Molecular Epidemiology of Tuberculosis

Updates on Clinical and Molecular Epidemiology of Tuberculosis PDF Author: Weimin Li
Publisher: Frontiers Media SA
ISBN: 2832535984
Category : Medical
Languages : en
Pages : 163

Get Book Here

Book Description
Addressing the tuberculosis (TB) epidemic is crucial to reduce morbidity, mortality, and health-care burden. Cases of confirmed drug-resistant TB have almost doubled over the past decade. Drug resistance represents one of leading causes of death among TB patients and is responsible for approximately one-third of TB-related deaths worldwide, which is associated with TB recurrence and transmission. In recent years, the emerging molecular epidemiology methods have attributed to better TB management. For example, in many settings, studies using molecular epidemiology methods have demonstrated the recent transmission of Mycobacterium tuberculosis (M. TB) strains. However, the transmission patterns of drug-resistant TB in most low- and middle- income developing countries remain unclear. Traditional transmission models based on clinical and epidemiological parameters were not sufficient to identify potential risk factors. By using molecular epidemiology analysis, further insights can be gained into the association between M. TB isolates and epidemic populations. This makes molecular epidemiology studies effective measures to establish phylogenetic relationships with clinical patients, identify clusters and track TB transmission. Studies investigating clinical and molecular epidemiology will provide theoretical basis and scientific strategy for TB prevention and control. We hope to address the TB-associated health-care burden, and the current insufficient or imprecise control strategies for TB management. More importantly, we would like to discuss more efficient approaches in this field with the development of molecular epidemiology method and share insights to reduce TB burden.

Updates on Clinical and Molecular Epidemiology of Tuberculosis

Updates on Clinical and Molecular Epidemiology of Tuberculosis PDF Author: Weimin Li
Publisher: Frontiers Media SA
ISBN: 2832535984
Category : Medical
Languages : en
Pages : 163

Get Book Here

Book Description
Addressing the tuberculosis (TB) epidemic is crucial to reduce morbidity, mortality, and health-care burden. Cases of confirmed drug-resistant TB have almost doubled over the past decade. Drug resistance represents one of leading causes of death among TB patients and is responsible for approximately one-third of TB-related deaths worldwide, which is associated with TB recurrence and transmission. In recent years, the emerging molecular epidemiology methods have attributed to better TB management. For example, in many settings, studies using molecular epidemiology methods have demonstrated the recent transmission of Mycobacterium tuberculosis (M. TB) strains. However, the transmission patterns of drug-resistant TB in most low- and middle- income developing countries remain unclear. Traditional transmission models based on clinical and epidemiological parameters were not sufficient to identify potential risk factors. By using molecular epidemiology analysis, further insights can be gained into the association between M. TB isolates and epidemic populations. This makes molecular epidemiology studies effective measures to establish phylogenetic relationships with clinical patients, identify clusters and track TB transmission. Studies investigating clinical and molecular epidemiology will provide theoretical basis and scientific strategy for TB prevention and control. We hope to address the TB-associated health-care burden, and the current insufficient or imprecise control strategies for TB management. More importantly, we would like to discuss more efficient approaches in this field with the development of molecular epidemiology method and share insights to reduce TB burden.

Laboratory Methods for Clinical and Public Health

Laboratory Methods for Clinical and Public Health PDF Author: George P. Kubica
Publisher:
ISBN:
Category : Medical bacteriology
Languages : en
Pages : 96

Get Book Here

Book Description


Clinical Tuberculosis

Clinical Tuberculosis PDF Author: Peter D. O. Davies
Publisher: CRC Press
ISBN: 0429586493
Category : Medical
Languages : en
Pages : 482

Get Book Here

Book Description
Completely updated and revised, Clinical Tuberculosis continues to provide the TB practitioner-whether in public health, laboratory science or clinical practice-with a synoptic and definitive account of the latest methods of diagnosis, treatment and control of this challenging and debilitating disease.New in the Fifth Edition:Gamma interferon-based

Cumulated Index Medicus

Cumulated Index Medicus PDF Author:
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1860

Get Book Here

Book Description


Public Health Mycobacteriology

Public Health Mycobacteriology PDF Author: Patricia T. Kent
Publisher:
ISBN:
Category : Medical bacteriology
Languages : en
Pages : 222

Get Book Here

Book Description


Tuberculosis in Animals: An African Perspective

Tuberculosis in Animals: An African Perspective PDF Author: Asseged B. Dibaba
Publisher: Springer
ISBN: 3030186903
Category : Science
Languages : en
Pages : 448

Get Book Here

Book Description
This book recounts the biology of M. bovis, followed by the status of bovine Tuberculosis (bTB) in African countries, primarily based on zoonotic and epidemiological field reports. Since the accumulation of data is valueless unless it led to practicable control measures, emphasis is put on locally adapted protocols for future control of the disease. In order to systematically evaluate the knowledge base of bTB, Epidemiologic Problem Oriented Approach (EPOA) methodology was used. The methodology is composed of two triads: i) the problem identification/characterization triad, which is mainly descriptive in nature, and ii) the problem management/solution/mitigation triad, which is mainly geared toward problem management/solution (see figure). The first triad comprises three pillars: i) agent ii) host, and iii) environment and the second one: i) therapeutics/treatment, ii) prevention/control, and iii) health maintenance/promotion. The two triads are linked together by the diagnostic procedure linkage. The systematic and detailed studies of the ‘Host-Agent-Environment’ interactions are the building blocks to the understanding of agent transmission pathways and disease spread. These may include data about the disease status of the country, the nature of the disease agent and its hosts, the modes of transmission, the wildlife reservoirs in nature, persistence of infection, and agent survival in animal products and the environment. The problem identification and characterization triad identifies these interactions. Once a problem has been identified and well understood, the next step is to minimize the risk of transmission and spread of a disease. This area, referred to as problem solution/management triad, consists of problem management alternatives that rely upon prevention/control, and health maintenance/promotion of the disease in livestock, wildlife, and humans with the emphasis on resource-poor, developing countries in Africa.

WHO consolidated guidelines on drug-resistant tuberculosis treatment

WHO consolidated guidelines on drug-resistant tuberculosis treatment PDF Author: World Health Organization
Publisher: World Health Organization
ISBN: 9789241550529
Category : Medical
Languages : en
Pages : 0

Get Book Here

Book Description
Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult to treat than drug-susceptible ones, and threaten global progress towards the targets set by the End TB Strategy of the World Health Organization (WHO). There is thus a critical need for evidence-based policy recommendations on the treatment and care of patients with DR-TB, based on the most recent and comprehensive evidence available. In this regard, the WHO consolidated guidelines on drug-resistant tuberculosis treatment fulfil the mandate of WHO to inform health professionals in Member States on how to improve treatment and care for patients with DR-TB. Between 2011 and 2018, WHO has developed and issued evidence-based policy recommendations on the treatment and care of patients with DR-TB. These policy recommendations have been presented in several WHO documents and their associated annexes, including the WHO treatment guidelines for multidrug- and rifampicin-resistant tuberculosis, 2018 update, issued by WHO in December 2018. The policy recommendations in each of these guidelines have been developed by WHO-convened Guideline Development Groups (GDGs), using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach to summarize the evidence, and formulate policy recommendations and accompanying remarks. The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, including longer and shorter regimens, culture monitoring of patients on treatment, the timing of antiretroviral therapy (ART) in MDR/RR-TB patients infected with the human immunodeficiency virus (HIV), use of surgery for patients receiving MDR-TB treatment, and optimal models of patient support and care.

Encyclopedia of Infectious Diseases

Encyclopedia of Infectious Diseases PDF Author: Michel Tibayrenc
Publisher: John Wiley & Sons
ISBN: 0470114193
Category : Science
Languages : en
Pages : 807

Get Book Here

Book Description
Discover how the application of novel multidisciplinary, integrative approaches and technologies are dramatically changing our understanding of the pathogenesis of infectious diseases and their treatments. Each article presents the state of the science, with a strong emphasis on new and emerging medical applications. The Encyclopedia of Infectious Diseases is organized into five parts. The first part examines current threats such as AIDS, malaria, SARS, and influenza. The second part addresses the evolution of pathogens and the relationship between human genetic diversity and the spread of infectious diseases. The next two parts highlight the most promising uses of molecular identification, vector control, satellite detection, surveillance, modeling, and high-throughput technologies. The final part explores specialized topics of current concern, including bioterrorism, world market and infectious diseases, and antibiotics for public health. Each article is written by one or more leading experts in the field of infectious diseases. These experts place all the latest findings from various disciplines in context, helping readers understand what is currently known, what the next generation of breakthroughs is likely to be, and where more research is needed. Several features facilitate research and deepen readers' understanding of infectious diseases: Illustrations help readers understand the pathogenesis and diagnosis of infectious diseases Lists of Web resources serve as a gateway to important research centers, government agencies, and other sources of information from around the world Information boxes highlight basic principles and specialized terminology International contributions offer perspectives on how infectious diseases are viewed by different cultures A special chapter discusses the representation of infectious diseases in art With its multidisciplinary approach, this encyclopedia helps point researchers in new promising directions and helps health professionals better understand the nature and treatment of infectious diseases.

Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis

Guidelines for the Programmatic Management of Drug-Resistant Tuberculosis PDF Author: World Health Organization
Publisher:
ISBN: 9789241501583
Category : Medical
Languages : en
Pages : 0

Get Book Here

Book Description
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response to the Sixty-second World Health Assembly's resolution on prevention and control of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Resolution WHA62.15, adopted in 2009, calls on Member States to develop a comprehensive framework for the management and care of patients with drug-resistant TB. The recommendations contained in these guidelines address the most topical questions concerning the programmatic management of drug-resistant TB: case-finding, multidrug resistance, treatment regimens, monitoring the response to treatment, and selecting models of care. The guidelines primarily target staff and medical practitioners working in TB treatment and control, and partners and organizations providing technical and financial support for care of drug-resistant TB in settings where resources are limited.

Interventions for Tuberculosis Control and Elimination

Interventions for Tuberculosis Control and Elimination PDF Author: Hans L. Rieder
Publisher:
ISBN:
Category : Tuberculosis
Languages : en
Pages : 272

Get Book Here

Book Description